HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Nik Sol Selected Research
Nik Sol Research Topics
Disease
13
Neoplasms (Cancer)
05/2023 - 01/2014
3
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2023 - 01/2017
2
Neoplasm Metastasis (Metastasis)
05/2023 - 10/2020
2
Glioma (Gliomas)
11/2022 - 06/2015
2
Multiple Sclerosis
10/2020 - 07/2020
2
Glioblastoma (Glioblastoma Multiforme)
10/2020 - 09/2013
1
Ovarian Neoplasms (Ovarian Cancer)
01/2023
1
Lung Neoplasms (Lung Cancer)
01/2023
1
Pulmonary Hypertension
10/2022
1
Sarcoma (Soft Tissue Sarcoma)
05/2020
1
Aneuploidy (Aneuploid)
09/2013
Drug/Important Bio-Agent (IBA)
13
RNA (Ribonucleic Acid)
IBA
05/2023 - 11/2015
12
Biomarkers (Surrogate Marker)
IBA
01/2023 - 01/2014
6
tetraethylpyrazine (TEP)
IBA
01/2023 - 11/2015
3
Proteins (Proteins, Gene)
FDA Link
11/2022 - 01/2014
2
Messenger RNA (mRNA)
IBA
05/2023 - 11/2015
1
Nivolumab
IBA
05/2023
1
Complement System Proteins (Complement)
IBA
01/2023
1
Cell-Free Nucleic Acids
IBA
11/2022
1
AS 195
IBA
10/2022
1
Anticoagulants
IBA
10/2022
1
Circular RNA
IBA
09/2021
1
Nucleic Acids
IBA
06/2015
1
Protein Kinases (Protein Kinase)
IBA
01/2014
1
Phosphotransferases (Kinase)
IBA
01/2014
1
1- (4- (6- (2- (isopropylsulfonyl)phenylamino)- 9H- purin- 2- ylamino)- 3- ethoxyphenyl)piperidin- 4- ol
IBA
09/2013
1
Vincristine (Oncovin)
FDA Link
Generic
09/2013
1
Paclitaxel (Taxol)
FDA Link
Generic
09/2013
1
Antimitotic Agents
IBA
09/2013
Therapy/Procedure
1
Immunotherapy
05/2023
1
Therapeutics
11/2022